Patients received concomitant anticoagulant and aspirin and were randomized to 6 weeks versus 6 months of clopidogrel. There was no difference between the 2 groups in terms of the primary composite endpoint of death, MI, definite stent thrombosis, stroke, or TIMI major bleeding or in terms of the secondary bleeding endpoint of TIMI major bleeding at 9 The Bern PCI RegistryS7.4-10 is a pro- spective registry of consecutive patients who have undergone PCI for stable coronary artery disease or ACS at Bern University Hospital since 2009. Among patients who were discharged on triple therapy, there was no difference between 1 month versus >1 month of triple therapy in the primary composite endpoint of cardiac death, MI, stroke, definite stent thrombosis, or TIMI major bleeding at 1 year.S7.4-10 Although both the ISAR-TRIPLE trial and the Bern PCI Registry have limitations, the consistent find- ing in both patients with ACS and patients with stable ischemic heart disease suggests that with current drug-eluting stents, selecting bare metal stents to shorten the duration of DAPT is no longer indicated. Of the patients treated with triple therapy for 1 month in the Bern PCI Registry, 60% were treated with a current-gen- eration drug-eluting stent. 7.12. Device Detection of AF and Atrial Flutter (New) Recommendations for Device Detection of AF and Atrial Flutter Referenced studies that support new recommendations are summarized in Online Data Supplement 9. 